http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2766799-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_79ae6dd5bafbd2dd69035367385d754c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-007
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007
filingDate 2021-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2022-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b10a9428dce35fe4bcdd833b33720489
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a5b8fefe0e53673439f538ff472aae9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b785c74108646d258b7aeca5aac32be8
publicationDate 2022-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2766799-C1
titleOfInvention Method for penetrating keratoplasty in children with congenital corneal opacities
abstract FIELD: medicine.SUBSTANCE: invention refers to medicine, namely to ophthalmology and can be used for penetrating keratoplasty in children with congenital corneal opacities. For this, the recipient’s corneal flap is first dissected by 3/4 of the circumference. Donor flap is then placed on the recipient’s corneal flap. At 6 and 12 o’clock, provisional sutures are applied at the recipient-donor border. Thereafter, remaining 1/4 of the recipient’s flap is excised, and the recipient’s corneal flap is removed from the donor’s. Donor cornea is sutured in the recipient’s bed with interrupted sutures and a continuous blanket suture. Interrupted provisional sutures are removed in the nearest postoperative period.EFFECT: invention provides prevention of lens, iris prolapse and eyeball collapse with preservation of corneal transplant transparency.1 cl, 2 ex
priorityDate 2021-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2332971-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2257874-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004045443-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493418
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503618
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154028339
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36294
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID430187187
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4583

Total number of triples: 23.